NSE: JLHL | BSE: 543980

Mid-range Performer

Download real time

1396.10 -4.30 (-0.31%)

6,640 NSE+BSE Volume

NSE 05 Jan, 2026 3:31 PM (IST)

9,153.7

Market Cap

Below industry Median

Beta 1Year

Very Low volatility

Jupiter Life Line Hospitals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JLHL, BSE:543980 Jupiter Life Line Hospitals Ltd.

Search Inside the pdf :

Jupiter Life Line Hospitals Ltd.

11 Nov 2025

1396.10

-0.31%

Jupiter Life Line Hospitals (JLHL IN) Q2FY26 Result Update...

Buy: Jupiter Life Line Hospital...

Target

Prabhudas Lilladhar

Jupiter Life Line Hospitals Ltd. is trading below all available SMAs

Jupiter Life Line Hospitals Ltd.

05 Aug 2025, 12:00AM

1396.10

-0.31%

Jupiter Life Line Hospitals (JLHL IN) Q1FY26 Result Update...

Buy: Jupiter Life Line Hospital...

Prabhudas Lilladhar

JLHL's Q1 consolidated EBITDA grew by 20% YoY (flat QoQ) to Rs781mn, in line with our estimates, aided by higher ARPOB. Its operational efficiency has been strong in the competitive markets of MMR. The company reported revenue/EBITDA CAGR of 20%/25% over FY22-25. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term. We believe strategic greenfield expansions in densely populated micro-markets of western regions will drive sustainable...

Jupiter Life Line Ho.. has an average target of 1720.00 from 3 brokers.

Jupiter Life Line Hospitals Ltd.

04 Aug 2025, 12:00AM

1396.10

-0.31%

Inline quarter; capacity expansion on track; maintaining a Buy

Buy: Jupiter Life Line Hospital...

Target

Anand Rathi

In line with our estimates and the consensus, Jupiter Lifeline Hospital reported healthy Q1 figures, with revenue/EBITDA up 21%/22% y/y. PAT, however, dipped a tad, 1% y/y due to higher interest cost and depreciation charges.

Jupiter Life Line Ho.. has an average target of 1720.00 from 3 brokers.

Jupiter Life Line Hospitals Ltd.

13 May 2025

1396.10

-0.31%

Jupiter Life Line Hospitals (JLHL IN) Q4FY25 Result Update...

Buy: Jupiter Life Line Hospital...

Target

Prabhudas Lilladhar

JLHL's Q4 consolidated EBITDA grew by 26% YoY (4% QoQ) to Rs783mn, largely in line with our estimates, aided by higher ARPOB. Its operational efficiency has been strong in the competitive markets of MMR. The company reported revenue/EBITDA CAGR of 20%/25% over FY22-25. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term. We believe strategic greenfield expansions in densely populated micro-markets of western regions...

Jupiter Life Line Ho.. has an average target of 1720.00 from 3 brokers.

Jupiter Life Line Hospitals Ltd.

10 Feb 2025

1396.10

-0.31%

Healthy growth momentum across units; maintaining a Buy

Buy: Jupiter Life Line Hospital...

Anand Rathi

In line with our estimates and the consensus, Jupiter Lifeline Hospital reported healthy Q3 figures, with revenue/EBITDA/PAT up 18%/21%/20% y/y.

Jupiter Life Line Ho.. has an average target of 1720.00 from 3 brokers.

Jupiter Life Line Hospitals Ltd.

10 Feb 2025

1396.10

-0.31%